Peptide record

TPDB00864

Antibacterial Anticancer Antifungal Antioxidant Antiparasitic Antiviral Toxicity standard
34 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB00864
Antibacterial Anticancer Antifungal Antioxidant Antiparasitic Antiviral Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides Functional / health-promoting peptides
AntiBP3 dbAMP DRAMP Peptipedia SATPdb Antifungipept
standard
No
A 34-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
ITSISLCTPGCKTGALMGCNMKTATCHCSIHVSK
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C143H246N42O45S7
RDEQFWY
CT
3498.20
8.48
5
0
10
+3
0.38
0.415
71.76
Mammalian: 20 hour Yeast: 30 min E.coli: >10 hour
250
0.07
15
Residue Composition
number
2
A
0
R
1
N
0
D
5
C
0
E
0
Q
3
G
2
H
3
I
2
L
3
K
2
M
0
F
1
P
4
S
5
T
0
W
0
Y
1
V
Amino Acid Distribution
A: 2 R: 0 N: 1 D: 0 C: 5 E: 0 Q: 0 G: 3 H: 2 I: 3 L: 2 K: 3 M: 2 F: 0 P: 1 S: 4 T: 5 W: 0 Y: 0 V: 1
Chemical Descriptors
34 reviewed residue count
C143H246N42O45S7 sequence-only estimate (linear, free termini)
3498.20 sequence-only estimate (linear, free termini)
8.48 sequence-only estimate (linear, free termini)
+3 sequence-only estimate (linear, free termini)
0.38 sequence-only estimate (linear, free termini)
0.415 sequence-only estimate (linear, free termini)
Evidence Records 20 records
Evidence 1 Activity

Activity

MIC
Antibacterial
83.6 µg/mL

Target

A. viscosus

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class. DRAMP antibacterial activity supported by MIC records against bacterial target organisms.
spp., Streptococcus spp., Bacillus spp. (MIC 4.2-8.4), Clostridium spp. (MIC 1.1 ug/ml), A. viscosus (MIC 83.6 ug/ml), Peptostreptococcus spp., C. diphtheriae, G. vaginalis, M. smegmatis, P. acnes (MIC 2.1-8
Evidence 2 Activity

Activity

MIC
Antibacterial
2.1-8.4 µg/mL

Target

P. acnes

Source & Reference

dbAMP DRAMP

Other

us (MIC 83.6 ug/ml), Peptostreptococcus spp., C. diphtheriae, G. vaginalis, M. smegmatis, P. acnes (MIC 2.1-8.4 ug/ml) (Ref see AP1003), S. aureus or MRSA, and Gram- bacteria: C. jejune (MIC 1.1 ug/ml), H. in
Evidence 3 Activity

Activity

MIC
Antibacterial
1.1 µg/mL

Target

C. jejune

Source & Reference

dbAMP DRAMP

Other

is, P. acnes (MIC 2.1-8.4 ug/ml) (Ref see AP1003), S. aureus or MRSA, and Gram- bacteria: C. jejune (MIC 1.1 ug/ml), H. influenzae (MIC 66.9 ug/ml), H. pylori (MIC 0.3 ug/ml), and Neisseria spp (MIC 8.4 ug
Evidence 4 Activity

Activity

MIC
Antibacterial
66.9 µg/mL

Target

H. influenzae

Source & Reference

dbAMP DRAMP

Other

g/ml) (Ref see AP1003), S. aureus or MRSA, and Gram- bacteria: C. jejune (MIC 1.1 ug/ml), H. influenzae (MIC 66.9 ug/ml), H. pylori (MIC 0.3 ug/ml), and Neisseria spp (MIC 8.4 ug/ml). It also has spermicidal ef
Evidence 5 Activity

Activity

MIC
Antibacterial
0.3 µg/mL

Target

H. pylori

Source & Reference

dbAMP DRAMP

Other

s or MRSA, and Gram- bacteria: C. jejune (MIC 1.1 ug/ml), H. influenzae (MIC 66.9 ug/ml), H. pylori (MIC 0.3 ug/ml), and Neisseria spp (MIC 8.4 ug/ml). It also has spermicidal effect. Antibiofilm:bacteria:
Evidence 6 Activity

Activity

MIC
Antifungal
83.6 µg/mL

Target

A. viscosus

Source & Reference

dbAMP DRAMP Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class. DRAMP antifungal activity supported by activity records against fungal target organisms.
spp., Streptococcus spp., Bacillus spp. (MIC 4.2-8.4), Clostridium spp. (MIC 1.1 ug/ml), A. viscosus (MIC 83.6 ug/ml), Peptostreptococcus spp., C. diphtheriae, G. vaginalis, M. smegmatis, P. acnes (MIC 2.1-8
Evidence 7 Activity

Activity

MIC
Antifungal
2.1-8.4 µg/mL

Target

P. acnes

Source & Reference

dbAMP DRAMP Antifungipept

Other

us (MIC 83.6 ug/ml), Peptostreptococcus spp., C. diphtheriae, G. vaginalis, M. smegmatis, P. acnes (MIC 2.1-8.4 ug/ml) (Ref see AP1003), S. aureus or MRSA, and Gram- bacteria: C. jejune (MIC 1.1 ug/ml), H. in
Evidence 8 Activity

Activity

MIC
Antifungal
1.1 µg/mL

Target

C. jejune

Source & Reference

dbAMP DRAMP Antifungipept

Other

is, P. acnes (MIC 2.1-8.4 ug/ml) (Ref see AP1003), S. aureus or MRSA, and Gram- bacteria: C. jejune (MIC 1.1 ug/ml), H. influenzae (MIC 66.9 ug/ml), H. pylori (MIC 0.3 ug/ml), and Neisseria spp (MIC 8.4 ug
Evidence 9 Activity

Activity

MIC
Antifungal
66.9 µg/mL

Target

H. influenzae

Source & Reference

dbAMP DRAMP Antifungipept

Other

g/ml) (Ref see AP1003), S. aureus or MRSA, and Gram- bacteria: C. jejune (MIC 1.1 ug/ml), H. influenzae (MIC 66.9 ug/ml), H. pylori (MIC 0.3 ug/ml), and Neisseria spp (MIC 8.4 ug/ml). It also has spermicidal ef
Evidence 10 Activity

Activity

MIC
Antifungal
0.3 µg/mL

Target

H. pylori

Source & Reference

dbAMP DRAMP Antifungipept

Other

s or MRSA, and Gram- bacteria: C. jejune (MIC 1.1 ug/ml), H. influenzae (MIC 66.9 ug/ml), H. pylori (MIC 0.3 ug/ml), and Neisseria spp (MIC 8.4 ug/ml). It also has spermicidal effect. Antibiofilm:bacteria:
Evidence 11 Activity

Activity

MIC
Antiparasitic
83.6 µg/mL

Target

A. viscosus

Source & Reference

DRAMP

Other

Source Activity Label Source Definition
Antiparasitic
DRAMP antiparasitic activity supported by activity records against parasitic targets.
spp., Streptococcus spp., Bacillus spp. (MIC 4.2-8.4), Clostridium spp. (MIC 1.1 ug/ml), A. viscosus (MIC 83.6 ug/ml), Peptostreptococcus spp., C. diphtheriae, G. vaginalis, M. smegmatis, P. acnes (MIC 2.1-8
Evidence 12 Activity

Activity

MIC
Antiparasitic
2.1-8.4 µg/mL

Target

P. acnes

Source & Reference

DRAMP

Other

us (MIC 83.6 ug/ml), Peptostreptococcus spp., C. diphtheriae, G. vaginalis, M. smegmatis, P. acnes (MIC 2.1-8.4 ug/ml) (Ref see AP1003), S. aureus or MRSA, and Gram- bacteria: C. jejune (MIC 1.1 ug/ml), H. in
Evidence 13 Activity

Activity

MIC
Antiparasitic
1.1 µg/mL

Target

C. jejune

Source & Reference

DRAMP

Other

is, P. acnes (MIC 2.1-8.4 ug/ml) (Ref see AP1003), S. aureus or MRSA, and Gram- bacteria: C. jejune (MIC 1.1 ug/ml), H. influenzae (MIC 66.9 ug/ml), H. pylori (MIC 0.3 ug/ml), and Neisseria spp (MIC 8.4 ug
Evidence 14 Activity

Activity

MIC
Antiparasitic
66.9 µg/mL

Target

H. influenzae

Source & Reference

DRAMP

Other

g/ml) (Ref see AP1003), S. aureus or MRSA, and Gram- bacteria: C. jejune (MIC 1.1 ug/ml), H. influenzae (MIC 66.9 ug/ml), H. pylori (MIC 0.3 ug/ml), and Neisseria spp (MIC 8.4 ug/ml). It also has spermicidal ef
Evidence 15 Activity

Activity

MIC
Antiparasitic
0.3 µg/mL

Target

H. pylori

Source & Reference

DRAMP

Other

s or MRSA, and Gram- bacteria: C. jejune (MIC 1.1 ug/ml), H. influenzae (MIC 66.9 ug/ml), H. pylori (MIC 0.3 ug/ml), and Neisseria spp (MIC 8.4 ug/ml). It also has spermicidal effect. Antibiofilm:bacteria:
Evidence 16 Activity

Activity

MIC
Antiviral
83.6 µg/mL

Target

A. viscosus

Source & Reference

DRAMP

Other

Source Activity Label Source Definition
Antiviral
DRAMP antiviral activity supported by activity records against viral targets.
spp., Streptococcus spp., Bacillus spp. (MIC 4.2-8.4), Clostridium spp. (MIC 1.1 ug/ml), A. viscosus (MIC 83.6 ug/ml), Peptostreptococcus spp., C. diphtheriae, G. vaginalis, M. smegmatis, P. acnes (MIC 2.1-8
Evidence 17 Activity

Activity

MIC
Antiviral
2.1-8.4 µg/mL

Target

P. acnes

Source & Reference

DRAMP

Other

us (MIC 83.6 ug/ml), Peptostreptococcus spp., C. diphtheriae, G. vaginalis, M. smegmatis, P. acnes (MIC 2.1-8.4 ug/ml) (Ref see AP1003), S. aureus or MRSA, and Gram- bacteria: C. jejune (MIC 1.1 ug/ml), H. in
Evidence 18 Activity

Activity

MIC
Antiviral
1.1 µg/mL

Target

C. jejune

Source & Reference

DRAMP

Other

is, P. acnes (MIC 2.1-8.4 ug/ml) (Ref see AP1003), S. aureus or MRSA, and Gram- bacteria: C. jejune (MIC 1.1 ug/ml), H. influenzae (MIC 66.9 ug/ml), H. pylori (MIC 0.3 ug/ml), and Neisseria spp (MIC 8.4 ug
Evidence 19 Activity

Activity

MIC
Antiviral
66.9 µg/mL

Target

H. influenzae

Source & Reference

DRAMP

Other

g/ml) (Ref see AP1003), S. aureus or MRSA, and Gram- bacteria: C. jejune (MIC 1.1 ug/ml), H. influenzae (MIC 66.9 ug/ml), H. pylori (MIC 0.3 ug/ml), and Neisseria spp (MIC 8.4 ug/ml). It also has spermicidal ef
Evidence 20 Activity

Activity

MIC
Antiviral
0.3 µg/mL

Target

H. pylori

Source & Reference

DRAMP

Other

s or MRSA, and Gram- bacteria: C. jejune (MIC 1.1 ug/ml), H. influenzae (MIC 66.9 ug/ml), H. pylori (MIC 0.3 ug/ml), and Neisseria spp (MIC 8.4 ug/ml). It also has spermicidal effect. Antibiofilm:bacteria: